CLOs on the Move

Coosa Valley Medical Center

www.cvhealth.net

 
The CVMC Care Team is over 600 members strong, with nearly 40 active medical staff professionals and approximately 100 courtesy, consulting and Emergency Department staff members. 19 areas of medical specialization are currently represented through the state-of-the-art 248-bed facility, with plans for added services on the horizon. As an independent, non-profit hospital, CVMC is solely focused on delivering the highest quality of health care to Sylacauga and its surrounding communities.
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.cvhealth.net
  • 315 W. Hickory Street
    Sylacauga, AL USA 35150
  • Phone: 256.401.4000

Executives

Name Title Contact Details

Similar Companies

dbMotion

dbMotion is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Pittsburgh, PA. To find more information about dbMotion, please visit www.dbmotion.com

Virginia Mason Medical Center

Virginia Mason Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Seattle, WA. To find more information about Virginia Mason Medical Center, please visit www.vmmc.org

Office of the National Coordinator for Health Information Technology

The Office of the National Coordinator for Health Information Technology (ONC) is the lead agency charged with formulating the federal government’s health IT strategy and coordinating federal health IT policies, standards, programs, and investments. ONC is organizationally located within the Office of the Secretary for the U.S. Department of Health and Human Services (HHS). The position of National Coordinator was created in 2004, through an Executive Order, and legislatively mandated in the Health Information Technology for Economic and Clinical Health Act (HITECH Act) of 2009.

Health Weeks

Health Weeks is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Envisia Therapeutics

Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.